FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ronnie Luyun

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Tumor Cells, Cultured

Procedures

Concepts & Ideas

Blood Cell Count

Co-author Network

Publications

TOP 3
Prashant Sharma; Shivani S Shinde; Ronnie F Luyun
Waxing and waning lymphadenopathy.
Thanyanan Reungwetwattana; Nicholas F Reuter; Kendrith M Rowland; Steven E Schild; Katie Allen-Ziegler; Grace K Dy; James R Jett; Ronnie F Luyun; Sumithra J Mandrekar; Randolph S Marks; Julian R Molina; Alex A. Adjei
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study.
Aminah Jatoi; Howard L Ritter; Amylou Dueck; Phuong L Nguyen; Daniel A Nikcevich; Ronnie F Luyun; Bassam I Mattar; Charles L Loprinzi
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ronnie Luyun (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Prashant Sharma; Shivani S Shinde; Ronnie F Luyun
Waxing and waning lymphadenopathy.
The American journal of medicine 2013;126(5):e3-4.
2012: Thanyanan Reungwetwattana; Nicholas F Reuter; Kendrith M Rowland; Steven E Schild; Katie Allen-Ziegler; Grace K Dy; James R Jett; Ronnie F Luyun; Sumithra J Mandrekar; Randolph S Marks; Julian R Molina; Alex A. Adjei
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(5):919-22.
2010: Aminah Jatoi; Howard L Ritter; Amylou Dueck; Phuong L Nguyen; Daniel A Nikcevich; Ronnie F Luyun; Bassam I Mattar; Charles L Loprinzi
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).
Lung cancer (Amsterdam, Netherlands) 2010;68(2):234-9.
2005: Thomas E Witzig; Susan M Geyer; Irene M Ghobrial; David J Inwards; Rafael Fonseca; Paul J Kurtin; Stephen M Ansell; Ronnie F Luyun; Patrick J Flynn; Roscoe F Morton; Shaker R Dakhil; Howard Gross; Scott H Kaufmann
Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(23):5347-56.
2002: Jayesh Mehta; Seema Singhal; L Gordon; Martin S Tallman; S Williams; Ronnie F Luyun; MY Ali; Yu Oyama; M Villa; T Shook; Jane Winter
Cobe Spectra is superior to Fenwal CS 3000 Plus for collection of hematopoietic stem cells.
Bone marrow transplantation 2002;29(7):563-7.